News
52m
The World from PRX on MSNPEPFAR and the future of the global fight against HIVPEPFAR was launched in 2003 to stop the spread of HIV in Africa. Now, although some funding remains for the program, many of ...
South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...
2d
allAfrica.com on MSNBREAKING: SA gets R520-million to buy the twice-a-year anti-HIV jab — but there’s a snagSA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year ...
IAS 2025, the 13th IAS Conference on HIV Science, opened today with a call to accelerate access to long-acting HIV prevention and treatment innovations amid growing global funding challenges. Four ...
2d
AllAfrica on MSNMomentum Builds For Long-Acting HIV Solutions As IAS 2025 Spotlights Scientific Progress, Funding Challenges And Leaders' Calls To ActionNew WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...
FIMC published its first public-facing MTM requirements in 2024. The 32-page document is their “commitment to excellence,” ...
A new microchip invented by Scripps Research scientists can reveal how a person’s antibodies interact with viruses—using just a drop of blood. The technology offers researchers faster, clearer ...
President Donald Trump’s administration says it is ending the deployment of 2,000 National Guard troops sent to Los Angeles ...
Working remotely at home in New Hampshire, her children’s cheddar bunny crackers and Fruit Roll-Ups lured her to the pantry, ...
A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses-using just ...
1don MSN
Nebraska is suing Colorado over the amount of water it draws from the South Platte River, the latest in a long history of water rights ...
3don MSN
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, lenacapavir, as a tool in their efforts to fight HIV infections – especially for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results